CMV reactivation may induce antileukemic effects in HLA-C KIR ligand group homozygous but not heterozygous recipients following allogeneic peripheral blood stem cell transplantation

J Clausen; B Kircher; Jutta Auberger; P Schumacher; Christoph Grabmer; A Muhlbacher; G Gastl; D Nachbaur

CMV reactivation may induce antileukemic effects in HLA-C KIR ligand group homozygous but not heterozygous recipients following allogeneic peripheral blood stem cell transplantation

J Clausen
, B Kircher
, Jutta Auberger
, P Schumacher
, Christoph Grabmer
, A Muhlbacher
, G Gastl
, D Nachbaur

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center
Department of Transfusion Medicine

Research output: Contribution to journal › Abstract (Journal) › peer-review

Original language	English
Pages (from-to)	156-156
Journal	ONKOLOGIE
Volume	35
Publication status	Published - 2012

Cite this

Clausen, J., Kircher, B., Auberger, J., Schumacher, P., Grabmer, C., Muhlbacher, A., Gastl, G., & Nachbaur, D. (2012). CMV reactivation may induce antileukemic effects in HLA-C KIR ligand group homozygous but not heterozygous recipients following allogeneic peripheral blood stem cell transplantation. ONKOLOGIE , 35, 156-156.

Clausen, J ; Kircher, B ; Auberger, Jutta et al. / CMV reactivation may induce antileukemic effects in HLA-C KIR ligand group homozygous but not heterozygous recipients following allogeneic peripheral blood stem cell transplantation. In: ONKOLOGIE 2012 ; Vol. 35. pp. 156-156.

@article{c94b27e77aae4c3e95f5fac7f4ec4aba,

title = "CMV reactivation may induce antileukemic effects in HLA-C KIR ligand group homozygous but not heterozygous recipients following allogeneic peripheral blood stem cell transplantation",

author = "J Clausen and B Kircher and Jutta Auberger and P Schumacher and Christoph Grabmer and A Muhlbacher and G Gastl and D Nachbaur",

year = "2012",

language = "English",

volume = "35",

pages = "156--156",

journal = "ONKOLOGIE ",

issn = "0378-584X",

}

Clausen, J, Kircher, B, Auberger, J, Schumacher, P, Grabmer, C, Muhlbacher, A, Gastl, G & Nachbaur, D 2012, 'CMV reactivation may induce antileukemic effects in HLA-C KIR ligand group homozygous but not heterozygous recipients following allogeneic peripheral blood stem cell transplantation', ONKOLOGIE , vol. 35, pp. 156-156.

CMV reactivation may induce antileukemic effects in HLA-C KIR ligand group homozygous but not heterozygous recipients following allogeneic peripheral blood stem cell transplantation. / Clausen, J; Kircher, B; Auberger, Jutta et al.
In: ONKOLOGIE , Vol. 35, 2012, p. 156-156.

Research output: Contribution to journal › Abstract (Journal) › peer-review

TY - JOUR

T1 - CMV reactivation may induce antileukemic effects in HLA-C KIR ligand group homozygous but not heterozygous recipients following allogeneic peripheral blood stem cell transplantation

AU - Clausen, J

AU - Kircher, B

AU - Auberger, Jutta

AU - Schumacher, P

AU - Grabmer, Christoph

AU - Muhlbacher, A

AU - Gastl, G

AU - Nachbaur, D

PY - 2012

Y1 - 2012

M3 - Abstract (Journal)

SN - 0378-584X

VL - 35

SP - 156

EP - 156

JO - ONKOLOGIE

JF - ONKOLOGIE

ER -

Clausen J, Kircher B, Auberger J, Schumacher P, Grabmer C, Muhlbacher A et al. CMV reactivation may induce antileukemic effects in HLA-C KIR ligand group homozygous but not heterozygous recipients following allogeneic peripheral blood stem cell transplantation. ONKOLOGIE . 2012;35:156-156.